1. Old opioids, new concerns: the case of acetylfentanyl

   • Maria Katselou
   • Ioannis Papoutsis
   • Sotiris Athanaselis

   Review Article 09 March 2016 Pages: 201 - 212

   

2. Chemical characterization and in vitro cyto- and genotoxicity of ‘legal high’ products containing Kratom (Mitragyna speciosa)

   • Ana Sofia Oliveira
   • Sónia Fraga
   • Paula Guedes de Pinho

   Original Article 03 February 2016 Pages: 213 - 226

   

3. Blood concentrations of α-pyrrolidinovalerophenone (α-PVP) determined in 66 forensic samples

   • Piotr Adamowicz
   • Joanna Gieroń
   • Dariusz Zuba

   Original Article 01 February 2016 Pages: 227 - 234

   

4. Postmortem blood concentrations of sartans measured by liquid chromatography-tandem mass spectrometry

   • Merja Gergov
   • Raimo A. Ketola

   Original Article 02 March 2016 Pages: 235 - 243

   

5. Simultaneous determination of cyclic antidepressants and their related drugs and the estimation of new metabolites in human whole blood and urine by MALDI-QTOF-mass spectrometry

   • Hideki Nozawa
   • Kayoko Minakata
   • Kanako Watanabe

   Original Article 01 April 2016 Pages: 244 - 255

   

6. Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes

   • Xingxing Diao
   • Karl B. Scheidweiler
   • Marilyn A. Huestis

   Original Article Open access 28 March 2016 Pages: 256 - 267

   

7. Application of high-resolution mass spectrometry to determination of baclofen in a case of fatal intoxication

   • Paweł Szpot
   • Agnieszka Chłopaś
   • Grzegorz Teresiński

   Original Article Open access 29 March 2016 Pages: 268 - 276

   

8. Pharmacokinetics of heroin and its metabolites in vitreous humor and blood in a living pig model

   • André Gottås
   • Marianne Arnestad
   • Gudrun Høiseth

   Original Article Open access 07 April 2016 Pages: 277 - 285

   

9. The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities

   • Mitchell Longworth
   • Samuel D. Banister
   • Michael Kassiou

   Original Article Open access 27 April 2016 Pages: 286 - 303

   

10. Regioisomeric differentiation of the alkyl-substituted synthetic cannabinoids JWH-122 and JWH-210 by GC-EI-MS/MS

    • Maiko Kusano
    • Mayumi Yamanaka
    • Akira Ishii

    Original Article 27 April 2016 Pages: 304 - 315

    

11. Human urinary metabolite pattern of a new synthetic cannabimimetic, methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate

    • Andrej Grigoryev
    • Pierce Kavanagh
    • Alexandr Pechnikov

    Original Article 23 April 2016 Pages: 316 - 328

    

12. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice

    • Cornelius Hess
    • Clara T. Schoeder
    • Christa E. Müller

    Original Article Open access 17 May 2016 Pages: 329 - 343

    

13. Absolute configuration of the synthetic cannabinoid MDMB-CHMICA with its chemical characteristics in illegal products

    • Lars Andernach
    • Stefan Pusch
    • Till Opatz

    Original Article 01 June 2016 Pages: 344 - 352

    

14. In vitro elucidation of the metabolic profile of the synthetic cannabinoid receptor agonists JWH-175 and JWH-176

    • Mathias Fietzke
    • Andreas Thomas
    • Katja Mercer-Chalmers-Bender

    Original Article 02 June 2016 Pages: 353 - 362

    

15. Application of MALDI-QTOF mass spectrometry to the determination of timiperone in whole blood, and estimation of its new metabolites in urine of a deceased subject who had been treated with timiperone antemortem

    • Hideki Nozawa
    • Kayoko Minakata
    • Kanako Watanabe

    Original Article 01 June 2016 Pages: 363 - 371

    

16. Chiral enantioresolution of cathinone derivatives present in “legal highs”, and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV)

    • Bárbara Silva
    • Carla Fernandes
    • Fernando Remião

    Original Article Open access 13 June 2016 Pages: 372 - 385

    

17. Drug-drug interactions and masking effects in sport doping: influence of miconazole administration on the urinary concentrations of endogenous anabolic steroids

    • Amelia Palermo
    • Francesco Botrè
    • Monica Mazzarino

    Original Article 20 June 2016 Pages: 386 - 397

    

18. Successful quantification of 4′-methyl-α-pyrrolidinohexanophenone (MPHP) in human urine using LC–TOF-MS in an autopsy case

    • Kaori Shintani-Ishida
    • Yasuhiro Kakiuchi
    • Hiroshi Ikegaya

    Short Communication Open access 04 February 2016 Pages: 398 - 402

    

19. New psychoactive substance α-PVP in a traffic accident case

    • Sebastian Rojek
    • Karol Kula
    • Małgorzata Kłys

    Case Report Open access 02 April 2016 Pages: 403 - 410

    

20. Determination of 1-phenyl-2-propanone (P2P) by HS-GC/MS in a material sold as “wet amphetamine”

    • Sebastiano Arnoldi
    • Gabriella Roda
    • Veniero Gambaro

    Case Report 28 March 2016 Pages: 411 - 418

    

21. Postmortem investigation of 88-cm-long dreadlocks for drugs of abuse: an unusual case report in the northeast of Germany

    • Ricarda Kegler
    • Andreas Büttner
    • Daniel Rentsch

    Case Report 30 April 2016 Pages: 419 - 424